Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CD248 contributors: mct/npt - updated : 22-04-2010
HGNC name CD248 molecule, endosialin
HGNC id 18219
Location 11q13.2      Physical location : 66.081.957 - 66.084.515
Synonym name
  • tumor endothelial marker 1 precursor
  • endosialin
  • CD248 antigen, endosialin
  • CD164 sialomucin-like 1
  • CD248 antigen
  • Synonym symbol(s) FB5, TEM1, CD164L1, MGC119478, MGC119479
    DNA
    TYPE functioning gene
    SPECIAL FEATURE arranged in tandem
    STRUCTURE 2.58 kb     1 Exon(s)
    MAPPING cloned Y linked N status provisional
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    1 - 2576 - 757 - Bagley (2008)
    EXPRESSION
    Type restricted
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Digestiveintestinelarge intestinecolon moderately
    Reproductivefemale systemuteruscervix highly
     female systemplacenta  highly
     male systemprostate  moderately
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Connectivebone   
    cells
    SystemCellPubmedSpeciesStageRna symbol
    Cardiovascularendothelial cell
    cell lineage
    cell lines metastatic cell lines and neoplastic endothelial cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • a signal peptide
  • one SUSHI/scr/ccp domain
  • calcium binding EGF-like domain
  • five globular extracellular domains including the C type lectin domain
  • three EGF repeats
  • one mucin-like region
  • conjugated GlycoP
    HOMOLOGY
    Homologene
    FAMILY
    CATEGORY receptor
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm
    basic FUNCTION
  • cell surface glycoprotein playing an important role in tumor progression
  • may have complementary functions with thrombomodulin in tumor progression
  • role in controlling the interaction among tumor cells, endothelia, and stromal matrix (2007)
  • highly O-glycosylated transmembrane glycoprotein, which is specifically expressed by tumor vessel-associated pericytes and stromal fibroblasts of a wide range of human tumors (Becker 2008)
  • involved in the earlier stages of tumor angiogenesis (Bagley 2008)
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • LGALS3BP specific interaction partner (Becker 2008)
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in colorectal cancer
    tumoral     --over  
    in highly invasive glioblastoma multiforme, anaplastic astrocytomas, and metastatic carcinomas
    constitutional        
    silencing in fibroblasts strongly inhibited migration and proliferation (Christian 2008)
    tumoral     --over  
    observed in many cancers of various tissue origin, including colon, breast, pancreatic, and lung (Tomkowicz 2007)
    tumoral        
    led to an increase in small immature blood vessels and decreased numbers of medium and large tumor vessels (Tomkowicz 2007)
    tumoral     --over  
    in primary and metastatic human brain tumors, where it localized primarily to the tumor vasculature and a subset of tumor stromal cells (Carson-Walter 2009)
    Susceptibility
    Variant & Polymorphism
    Candidate gene
  • marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells (Christian 2008)
  • Marker
    Therapy target
  • cellular localization of TEM1/endosialin and its expression profile in primary and metastatic brain tumors support efforts to therapeutically target this protein, potentially via antibody mediated drug delivery strategies (Carson-Walter 2009)
  • ANIMAL & CELL MODELS